8:45am ET
Investing
Huge Insider Buying in MGM and Salesforce
As the year winds down, insiders make huge buys in MGM Resorts and Salesforce. However, those were not the only notable instances of insider buying seen recently.
Companies
/Healthcare
Viridian Therapeutics Inc
$22.73
▼ $0.44 (−1.90%) today
Markets closed · 12:35am ET
Today · % change
Fundamentals
Market Cap
$2.6B
Revenue (TTM)
$71.1M
EPS (TTM)
$-3.40
52-Week Range
$13 – $34
Street Target
$36.62
About Viridian Therapeutics
Viridian Therapeutics, Inc., based in Waltham, Massachusetts, is a biotechnology firm focused on developing treatments for serious and rare diseases. Its leading projects include VRDN-001, a monoclonal antibody for thyroid eye disease, now in Phase 3 trials, and VRDN-003, a next-generation antibody with potential for the same condition. The company also explores treatments for autoimmune diseases through its preclinical programs VRDN-006 and VRDN-008. Founded in 2010 and originally known as Miragen Therapeutics, it rebranded to Viridian Therapeutics in 2021.
VRDN Coverage
2:21pm ET
Investing
Insiders Are Buying These 3 Stocks Hand Over Fist
Insider buys can be a telltale sign of a turnaround, as these investments give you a window into where management stands with a company. Studies have shown that insider buys often lead…
9:15am ET
Investing
Last Week’s 3 Biotech IPOs Prompt Huge Insider Buying
IPOs at three biotechs last week tempted insiders to make huge purchases of shares. This effect spilled over into buying at a couple of other biotechs as well.
1:09pm ET
Investing
Huge Insider Buys From Warren Buffett, Jack Ma, Carlos Slim and More
Recent insider buying has been highlighted by purchases by Warren Buffett, Jack Ma, Carlos Slim, and John Paulson. Biotechs tempted insiders, as did public offerings.